Article Information
History
- September 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yajuan J. Liu1,*,
- Wenjing Wang1,
- Jeffrey Yeh2,
- Yu Wu1,
- Jose G. Mantilla1,
- Christopher D.M. Fletcher3,
- Robert W. Ricciotti1 and
- Eleanor Y. Chen1,*
- 1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States
- 2Department of Biology, University of Washington, Seattle, Washington, United States
- 3Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States
- ↵*Correspondence: Eleanor Y. Chen, MD, PhD, Associate Professor, Department of Pathology, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, Box 357470, Email: eleanor2{at}uw.edu, Yajuan Liu, PhD, Associate Professor, Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, Box 357470, Email: yajuan{at}uw.edu
Posted September 03, 2020.
Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including MERTK, TEK, FGFR2, and FGFR1: a molecular and clinicopathologic analysis
